Therapies with botulinum toxin (for instance Botox®, Dysport®, Xeomin®)   are approved for dystonia, spastiticity, chronic migraine in the European Union.
Not yet approved, but efficacious indications embrace sialorrhea  (increased drooling), hyperhidrosis (increased sweating), the cosmetic treatment of wrinkles, bruxism, and muscle spasms. Anecdotal evidence suggests that depressive disorders may be improved by botulinum toxin, although these studies certainly await verification.

NEUROLOGY-MOVES may support you concerning insurance issues. However and independently, we offer these treatment options following individual reimbursement. 

We will be glad to provide medical certificates, additional exams, and copies upon request and reimbursement.

Deep brain stimulation has revolutionized therepeutic options in movement disorders. Additionally, its potential benefits are presently investigated in depression, alcohol abuse, obsessive compulsive disorders, cluster headache, and infantile cerebral palsy. These therapeutic avenues are experimental and normally require participation in clinical trials, enabling scientific evaluation. We look forward to inform about these new possibilities. 

In uncertain cases of suspected memory deficits   we provide comprehensive memory testing via validated international batteries (for instance CERAD), which will be reimbursed individually (according to German guidelines, GOÄ).

Increased sweating may severely impair quality of life, for instance social competence. Therapy with botulinum toxin has been shown to be highly efficacious with little adverse events. In the European Union the reimbursement for this clearly efficient therapeutic option has not been finalized yet. We will try to provide support in potential insurance issue. Independently and more importantly, we offer this treatment on an individual basis .  

The investigation of nerve lesions via ultrasound may permit to more specifically locate lesions (plexus- and compression syndromes). NEUROLOGY MOVES offers these investigations in cooperation with Dr. Böhm/Dr. Raffauf in Berlin and in cooperation with the Universities of Magdeburg (Prof. Vielhaber) and Erlangen (Dr. Axel Schramm).

Knowledge on neurological risks in pregnancy concerning drugs and diseases is still sparse. Independently we will try to advise in these issues, especially treatment in epilepsy, Botulinum toxin, Dystonia, Parkinson´disease, multiple sclerosis and other indications.

Applications of botulinum toxin are efficient in excessive drooling  (Sialorrhea). NEUROLOGY MOVES showed in 2003 that injections of botulinum toxin in saliva-producing glands significantly reduces drooling in Parkinsons´s disease or other neruological disorders.  (PubMed Link) We will be glad to provide medical advise.

Sonography or ultrasound are increasingly employed to potentially  increase the therepeutic efficacy of botulinum toxin in spasticity or dystonia. Scientifically it is still debated, if this diagnostic advance translates into therapeutic advangates. NEUROLOGY MOVES participates in these endavours to improve therapy with botulinum toxin in dystonia & spasticity and nerve compression syndromes.